Abstract
Original language | English |
---|---|
Journal | Sci. Rep. |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2020 |
Fingerprint
Dive into the research topics of 'Long-term exposure of human endothelial cells to metformin modulates miRNAs and isomiRs: Scientific Reports'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Long-term exposure of human endothelial cells to metformin modulates miRNAs and isomiRs : Scientific Reports. / Giuliani, A.; Londin, E.; Ferracin, M. et al.
In: Sci. Rep., Vol. 10, No. 1, 2020.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Long-term exposure of human endothelial cells to metformin modulates miRNAs and isomiRs
T2 - Scientific Reports
AU - Giuliani, A.
AU - Londin, E.
AU - Ferracin, M.
AU - Mensà, E.
AU - Prattichizzo, F.
AU - Ramini, D.
AU - Marcheselli, F.
AU - Recchioni, R.
AU - Rippo, M.R.
AU - Bonafè, M.
AU - Rigoutsos, I.
AU - Olivieri, F.
AU - Sabbatinelli, J.
N1 - Export Date: 5 March 2021 Correspondence Address: Olivieri, F.; Department of Clinical and Molecular Sciences, Via Tronto 10/A, Italy; email: f.olivieri@univpm.it Funding details: Ministero della Salute, Ricerca corrente Funding details: Università Politecnica delle Marche, UNIVPM, RSA grant Funding text 1: This work was supported by grants from Università Politecnica delle Marche [Scientific research grant, years 2017–2018–2019 to F.O. and M.R.R.] and by the Italian Ministry of Health [“Ricerca corrente” to IRCCS INRCA and IRCCS MultiMedica]. References: Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020 (2020) Diabetes Care, 43, pp. SS98-S110. , https://doi.org/10.2337/dc20-S009, 1, . 9, , . doi:, (,); Salvatore, T., Metformin: an old drug against old age and associated morbidities (2020) Diabetes Res. Clin. Pract., 160, p. 108025; Han, Y., Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis (2019) Cardiovasc. Diabetol., 18, p. 96; Campbell, J.M., Bellman, S.M., Stephenson, M.D., Lisy, K., Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis (2017) Ageing Res. Rev., 40, pp. 31-44; Barzilai, N., Crandall, J.P., Kritchevsky, S.B., Espeland, M.A., Metformin as a tool to target aging (2016) Cell Metab., 23, pp. 1060-1065; Prattichizzo, F., Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing (2018) Ageing Res. Rev., 48, pp. 87-98; Moiseeva, O., Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation (2013) Aging Cell, 12, pp. 489-498; Rena, G., Hardie, D.G., Pearson, E.R., The mechanisms of action of metformin (2017) Diabetologia, 60, pp. 1577-1585; Song, Y.M., Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway (2015) Autophagy, 11, pp. 46-59; Giblin, W., Skinner, M.E., Lombard, D.B., Sirtuins: guardians of mammalian healthspan (2014) Trends Genet., 30, pp. 271-286; Bridgeman, S.C., Ellison, G.C., Melton, P.E., Newsholme, P., Mamotte, C.D.S., Epigenetic effects of metformin: from molecular mechanisms to clinical implications (2018) Diabetes Obes. Metab., 20, pp. 1553-1562; Noren Hooten, N., Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence (2016) Aging Cell, 15, pp. 572-581; Williams, J., Smith, F., Kumar, S., Vijayan, M., Reddy, P.H., Are microRNAs true sensors of ageing and cellular senescence? (2017) Ageing Res. Rev., 35, pp. 350-363; Tam, S., de Borja, R., Tsao, M.S., McPherson, J.D., Robust global microRNA expression profiling using next-generation sequencing technologies (2014) Lab. Invest., 94, pp. 350-358; Morin, R.D., Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells (2008) Genome Res, 18, pp. 610-621; Telonis, A.G., Loher, P., Jing, Y., Londin, E., Rigoutsos, I., Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity (2015) Nucleic Acids Res, 43, pp. 9158-9175; Loher, P., Londin, E.R., Rigoutsos, I., IsomiR expression profiles in human lymphoblastoid cell lines exhibit population and gender dependencies (2014) Oncotarget, 5, pp. 8790-8802; Yang, A., 3' uridylation confers miRNAs with non-canonical target repertoires (2019) Mol. Cell, 75, pp. 511-522; van der Kwast, R., Woudenberg, T., Quax, P.H.A., Nossent, A.Y., MicroRNA-411 and its 5'-IsomiR have distinct targets and functions and are differentially regulated in the vasculature under ischemia (2020) Mol. Ther., 28, pp. 157-170; Koppers-Lalic, D., Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes (2014) Cell Rep., 8, pp. 1649-1658; Giuliani, A., The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells (2018) Aging (Albany NY), 10, pp. 2855-2873; Mensà, E., Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells (2020) J. Extracell. Vesic., 9, p. 1725285; Gu, S., The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo (2012) Cell, 151, pp. 900-911; Bofill-De Ros, X., Structural differences between Pri-miRNA Paralogs promote alternative drosha cleavage and expand target repertoires (2019) Cell Rep., 26, pp. 447-459; Haseeb, A., Makki, M.S., Khan, N.M., Ahmad, I., Haqqi, T.M., Deep sequencing and analyses of miRNAs, isomiRs and miRNA induced silencing complex (miRISC)-associated miRNome in primary human chondrocytes (2017) Sci. Rep., 7, p. 15178; Bofill-De Ros, X., Yang, A., Gu, S., IsomiRs: expanding the miRNA repression toolbox beyond the seed (2020) Biochim. Biophys. Acta Gene Regul. Mech., 1863, p. 194373; Howell, J.J., Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex (2017) Cell Metab., 25, pp. 463-471; Olivieri, F., Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging (2017) Mech. Ageing Dev., 165, pp. 162-170; Fulop, T., Witkowski, J.M., Olivieri, F., Larbi, A., The integration of inflammaging in age-related diseases (2018) Semin. Immunol., 40, pp. 17-35; Prattichizzo, F., Endothelial cell senescence and inflammaging: MicroRNAs as biomarkers and innovative therapeutic tools (2016) Curr. Drug Targets, 17, pp. 388-397; Mensà, E., Circulating miR-146a in healthy aging and type 2 diabetes: age- and gender-specific trajectories (2019) Mech. Ageing Dev., 180, pp. 1-10; Olivieri, F., Prattichizzo, F., Grillari, J., Balistreri, C.R., Cellular senescence and inflammaging in age-related diseases (2018) Mediat. Inflamm., 2018, p. 9076485; Sabbatinelli, J., Where metabolism meets senescence: focus on endothelial cells (2019) Front. Physiol., 10, p. 1523; Wang, B., Microrna-217 modulates human skin fibroblast senescence by directly targeting DNA methyltransferase 1 (2017) Oncotarget, 8, pp. 33475-33486; Menghini, R., MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1 (2009) Circulation, 120, pp. 1524-1532; Menghini, R., MiR-216a: a link between endothelial dysfunction and autophagy (2014) Cell Death Dis., 5; Yang, S., MicroRNA-216a induces endothelial senescence and inflammation via Smad3/IkappaBalpha pathway (2018) J. Cell. Mol. Med., 22, pp. 2739-2749; Yang, S., MicroRNA-216a promotes M1 macrophages polarization and atherosclerosis progression by activating telomerase via the Smad3/NF-kappaB pathway (1865) Biochim. Biophys. Acta Mol. Basis Dis., 1772-1781, p. 2019; Kuosmanen, S.M., Sihvola, V., Kansanen, E., Kaikkonen, M.U., Levonen, A.L., MicroRNAs mediate the senescence-associated decline of NRF2 in endothelial cells (2018) Redox. Biol., 18, pp. 77-83; Luo, X., Hu, R., Zheng, Y., Liu, S., Zhou, Z., Metformin shows anti-inflammatory effects in murine macrophages through Dicer/microribonucleic acid-34a-5p and microribonucleic acid-125b-5p (2020) J. Diabetes Investig., 11, pp. 101-109; Mogilyansky, E., Rigoutsos, I., The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease (2013) Cell Death Differ, 20, pp. 1603-1614; Gebert, L.F.R., MacRae, I.J., Regulation of microRNA function in animals (2019) Nat. Rev. Mol. Cell Biol., 20, pp. 21-37; Boele, J., PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease (2014) Proc. Natl. Acad. Sci. USA, 111, pp. 11467-11472; Ameres, S.L., Zamore, P.D., Diversifying microRNA sequence and function (2013) Nat. Rev. Mol. Cell Biol., 14, pp. 475-488; Ameres, S.L., Target RNA-directed trimming and tailing of small silencing RNAs (2010) Science, 328, pp. 1534-1539; Ha, M., Kim, V.N., Regulation of microRNA biogenesis (2014) Nat. Rev. Mol. Cell Biol., 15, pp. 509-524; Gutierrez-Vazquez, C., 3' Uridylation controls mature microRNA turnover during CD4 T-cell activation (2017) RNA, 23, pp. 882-891; Le Pen, J., Terminal uridylyltransferases target RNA viruses as part of the innate immune system (2018) Nat. Struct. Mol. Biol., 25, pp. 778-786; Magee, R., Telonis, A.G., Cherlin, T., Rigoutsos, I., Londin, E., Assessment of isomiR discrimination using commercial qPCR methods (2017) Noncoding RNA, 3, p. 1; Wu, C.W., A comprehensive approach to sequence-oriented IsomiR annotation (CASMIR): demonstration with IsomiR profiling in colorectal neoplasia (2018) BMC Genomics, 19, p. 401; Martin, M., (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads., 17 (3), p. 2011; Kozomara, A., Birgaoanu, M., Griffiths-Jones, S., miRBase: from microRNA sequences to function (2019) Nucleic Acids Res, 47, pp. D155-D162; Dobin, A., STAR: ultrafast universal RNA-seq aligner (2013) Bioinformatics, 29, pp. 15-21; David, M., Dzamba, M., Lister, D., Ilie, L., Brudno, M., SHRiMP2: sensitive yet practical SHort read mapping (2011) Bioinformatics, 27, pp. 1011-1012; Magee, R.G., Telonis, A.G., Loher, P., Londin, E., Rigoutsos, I., Profiles of miRNA isoforms and tRNA fragments in prostate cancer (2018) Sci. Rep., 8, p. 5314; Londin, E., IsomiRs and tRNA-derived fragments are associated with metastasis and patient survival in uveal melanoma (2020) Pigment Cell Melanoma Res., 33, pp. 52-62; Telonis, A.G., Rigoutsos, I., Race disparities in the contribution of miRNA isoforms and tRNA-derived fragments to triple-negative breast cancer (2018) Cancer Res, 78, pp. 1140-1154; Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 (2014) Genome Biol., 15, p. 550; Marini, F., Binder, H., pcaExplorer: an R/Bioconductor package for interacting with RNA-seq principal components (2019) BMC Bioinformatics, 20, p. 331; Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K., Tanabe, M., New approach for understanding genome variations in KEGG (2019) Nucleic Acids Res., 47, pp. D590-D595; Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes (2000) Nucleic Acids Res., 28, pp. 27-30; Vlachos, I.S., DIANA-miRPath v3.0: deciphering microRNA function with experimental support (2015) Nucleic Acids Res., 43, pp. W460-W466
PY - 2020
Y1 - 2020
N2 - Increasing evidence suggest that the glucose-lowering drug metformin exerts a valuable anti-senescence role. The ability of metformin to affect the biogenesis of selected microRNAs (miRNAs) was recently suggested. MicroRNA isoforms (isomiRs) are distinct variations of miRNA sequences, harboring addition or deletion of one or more nucleotides at the 5′ and/or 3′ ends of the canonical miRNA sequence. We performed a comprehensive analysis of miRNA and isomiR profile in human endothelial cells undergoing replicative senescence in presence of metformin. Metformin treatment was associated with the differential expression of 27 miRNAs (including miR-100-5p, -125b-5p, -654-3p, -217 and -216a-3p/5p). IsomiR analysis revealed that almost 40% of the total miRNA pool was composed by non-canonical sequences. Metformin significantly affects the relative abundance of 133 isomiRs, including the non-canonical forms of the aforementioned miRNAs. Pathway enrichment analysis suggested that pathways associated with proliferation and nutrient sensing are modulated by metformin-regulated miRNAs and that some of the regulated isomiRs (e.g. the 5′ miR-217 isomiR) are endowed with alternative seed sequences and share less than half of the predicted targets with the canonical form. Our results show that metformin reshapes the senescence-associated miRNA/isomiR patterns of endothelial cells, thus expanding our insight into the cell senescence molecular machinery. © 2020, The Author(s).
AB - Increasing evidence suggest that the glucose-lowering drug metformin exerts a valuable anti-senescence role. The ability of metformin to affect the biogenesis of selected microRNAs (miRNAs) was recently suggested. MicroRNA isoforms (isomiRs) are distinct variations of miRNA sequences, harboring addition or deletion of one or more nucleotides at the 5′ and/or 3′ ends of the canonical miRNA sequence. We performed a comprehensive analysis of miRNA and isomiR profile in human endothelial cells undergoing replicative senescence in presence of metformin. Metformin treatment was associated with the differential expression of 27 miRNAs (including miR-100-5p, -125b-5p, -654-3p, -217 and -216a-3p/5p). IsomiR analysis revealed that almost 40% of the total miRNA pool was composed by non-canonical sequences. Metformin significantly affects the relative abundance of 133 isomiRs, including the non-canonical forms of the aforementioned miRNAs. Pathway enrichment analysis suggested that pathways associated with proliferation and nutrient sensing are modulated by metformin-regulated miRNAs and that some of the regulated isomiRs (e.g. the 5′ miR-217 isomiR) are endowed with alternative seed sequences and share less than half of the predicted targets with the canonical form. Our results show that metformin reshapes the senescence-associated miRNA/isomiR patterns of endothelial cells, thus expanding our insight into the cell senescence molecular machinery. © 2020, The Author(s).
U2 - 10.1038/s41598-020-78871-5
DO - 10.1038/s41598-020-78871-5
M3 - Article
VL - 10
JO - Sci. Rep.
JF - Sci. Rep.
SN - 2045-2322
IS - 1
ER -